Company / Operating Income per Share
Fulcrum Therapeutics, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1338.00
FY2025
5-year range
-$2501.86 / -$353.27
FY2021-FY2025
Trend
-278.7%
vs FY2024
Sector context
#200 of 201
Health Care
What the data says
Operating Income per Share changed -279% YoY in FY2025, a notable deviation from the 7-year average annual change of -4%.
Based on SEC 10-K filings.
-1338.00 in FY2025.
Improved from $-1804.99 to $-1338.00 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 201This company -$1338.00 Sector average -$28.56
▼
-4585.3% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 278.7% year-over-year.
- Ranks #200 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1338.00 | -278.7% |
| FY2024 | -$353.27 | +80.4% |
| FY2023 | -$1804.99 | +27.9% |
| FY2022 | -$2501.86 | -9.1% |
| FY2021 | -$2292.19 | +18.8% |
| FY2020 | -$2824.45 | +63.0% |
| FY2019 | -$7624.21 | +71.4% |
| FY2018 | -$26649.16 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026